If you enjoy this content, please share it with a colleague
RELATED CONTENT
A recently completed National Institutes of Health-funded trial confirms the efficacy of blood flow measurement technology from VasSol Inc. to predict the possibility of repeated stroke in at-risk individuals.
Increasingly software applications are providing many of the major advancements in magnetic resonance imaging (MRI) rather than hardware. In recent years, this has translated into software that enables physicians to do more in less time, extract more diagnostic information from imaging exams and provide more accurate quantification. While a hospital may not spend millions to upgrade its MRI system, it frequently takes advantage of the lower cost option of other vendors’ software to assess and manipulate those images.
November 21, 2011 — VasSol’s Noninvasive Optimum Vessel Analysis (NOVA) technology provides physicians with detailed, quantitative information of blood flow through any vessel in the brain. Information provided includes velocity, volume and direction.